Trentham D E, Dynesius-Trentham R A
Beth Israel Hospital, Division of Rheumatology, Boston, MA 02215, USA.
Rheum Dis Clin North Am. 1995 Aug;21(3):817-34.
Minocycline is arguably the most interesting new drug for rheumatoid arthritis since the development of methotrexate. Tetracycline compounds have long been used by rheumatologists who were considered mavericks by their peers, and recent controlled studies have demonstrated their antirheumatic activity. The reason that minocycline works is unclear, and their niche in the treatment of rheumatoid arthritis remains to be established. Nonetheless, it is clear that some patients with rheumatoid arthritis respond favorably to this form of treatment.
自甲氨蝶呤研发以来,米诺环素可谓是类风湿关节炎领域最引人关注的新药。长期以来,四环素类化合物一直被一些被同行视为特立独行的风湿病学家所使用,近期的对照研究已证实了它们的抗风湿活性。米诺环素发挥作用的原因尚不清楚,其在类风湿关节炎治疗中的定位仍有待确定。尽管如此,很明显一些类风湿关节炎患者对这种治疗方式反应良好。